GET THE APP

Identifying active molecules from Chinese her medicine with in silico and in vitro approaches
..

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Identifying active molecules from Chinese her medicine with in silico and in vitro approaches


International Conference and Exhibition on Molecular Medicine and Diagnostics

August 24-26, 2015 London, UK

Jun Xu

Posters-Accepted Abstracts: J Mol Genet Med

Abstract :

With the super computing support from TH-2, we have developed in silico tool kits to virtually screen Chinese herbs against
specific diseases, and identify the active molecules and their targets. The in silico study results then guide us to design our
in vitro experiments for bioassays and elucidating mechanisms of actions. Employing this protocol, we discovered Saururaceae
as the Epstein–Barr virus (EBV) inhibitor, and identified active molecules from Buzhong yiqi tang (Chinese compound herbal
medicine) for myasthenia gravis. Phytochemistry and chemoinformatics studies revealed the active compounds were lignans and
their target was topoisomerase 2 (Topo II) for the EBV inhibitors. With virtual and biological screening experiments, we revealed
that the active compounds of Buzhong yiqi tang were 2-phenyl-benzo heteropentacyclic mimics, which led to the discovery of new
acetylcholinesterase inhibitors. These methods pave new road for phenotypic and target based drug innovations.

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward